Position in IDYA
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$61,915,940
+$17,484,455 QoQ
Shares Held
1,661,281
+24.6% QoQ
Ownership
1.72%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#14
of 286 holders
Holding Since
Sep 2020
22 quarters on record
Voting authority
Sole 90%
Shared 6%
None 4%
Common Shares in IDYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,163,799,259 across 230 Biotechnology names. IDYA ranks #25 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in IDYA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $61,915,940 | 1,661,281 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $44,431,485 | 1,333,478 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $32,456,284 | 938,857 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $13,524,674 | 497,048 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,587,525 | 170,672 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,330,005 | 81,197 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $8,911,859 | 346,765 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $11,922,860 | 376,353 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $38,440,954 | 1,094,872 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $59,867,193 | 1,364,339 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $45,766,552 | 1,286,300 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $30,817,688 | 1,142,242 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $25,529,200 | 1,086,349 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $14,230,470 | 1,036,451 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $13,215,330 | 727,316 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $8,882,352 | 595,332 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $6,854,859 | 496,729 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $4,757,797 | 425,183 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $6,433,886 | 272,161 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $2,337,178 | 91,690 | Shares | Defined | 2021-11-12 | |
| 2020-12-31 | $574,938 | 41,067 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $354,832 | 28,251 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||